connecting the dots to find a cure for Systemic Juvenile Idiopathic Arthritis

Donate DONATE
MENUMENU
  • Home
  • Research Focus
  • Events
    • - Family Conf: 2019
    • - Family Conf: 2018 (past)
    • - NextGen Therapies - 2017
    • - Family Day: 2017
    • - NextGen Therapies: 2016
  • Patient Resources
    • Find Clinical Trials
    • Parents Advisory Board
  • About Us
  • Blog
  • Join Us
Home > Blog

Latest From the Blog

Next gen therapies for SJIA & MAS Conference Program (final)

Rashmi Sinha | October 19, 2016 | 1 Comment

Here is the final program for the Next Gen therapies conference. Post a comment if you have any questions.
read more

Mapping SJIA worldwide

Jonathan Boutelle | October 17, 2016 | Leave a Comment

Rashmi posted a survey on the facebook SJIA group and the Autoinflamatory disease group, to try to understand what medicines patients are using to control their disease. Here’s a map that shows the distribution of patients worldwide (results are still coming in so this will change over time).
read more

Next Gen Meds conference Draft Agenda

Rashmi Sinha | October 16, 2016 | Leave a Comment

conference_microphoneOur next conference is next here! Here is the draft agenda for the Next Gen Meds conference. Its in Washington DC from October 21st to Oct 23rd.read more

Research Presentations from SJIA/ILD Conference

Jonathan Boutelle | March 24, 2015 | Leave a Comment

participateHeaderImg-01
Here’s some more presentations from the Systemic JIA / ILD conference we helped organized at Stanford last month. These presentations go deeper into the cell biology than the previous set of presentations.read more

Clinical Presentations from SJIA / ILD conference

Jonathan Boutelle | March 24, 2015 | Leave a Comment

blogheaderimg-05
read more

TrialReach: a new way to match patients with clinical trials

Jonathan Boutelle | February 6, 2015 | Leave a Comment

blogheaderimg-04TrialReach is an interesting new service for matching clinical trials with patientsto develop their service for matching patients with available clinical trials. This is a really cool idea. One of the things holding back research into rare diseases like SJIA is getting enough participants into the clinical trials so that the research can happen.read more

Round up of clinical trials in Systemic JIA

Rashmi Sinha | February 6, 2015 | Leave a Comment

blogheaderimg-03We did a check on the awesome clinicaltrials.gov website recently to see what clinical trials were happening for SJIA. The good news is that there are 7 total: 4 that are currently recruiting for patients, and another 3 that are in the planning stages but haven’t started recruiting yet.read more

Ask your doctor if you are on the Consensus Treatment Plan for Systemic JIA

Ruth Hickman | February 6, 2015 | Leave a Comment

blogheaderimg-05In July 2012, a group of researchers from CARRA (the Childhood Arthritis and Rheumatology Research Alliance) issued recommendations to help doctors standardize treatment plans for children with systemic juvenile idiopathic arthritis (sJIA). With the introduction of biologics in the past decade, the number of drugs used to treat sJIA has dramatically increased. Unfortunately, there are no studies directly comparing these drugs in patients with sJIA. Before these recommendations, clinicians used their own experience to develop treatment plans, resulting in a wide variation in drugs used, dosage, and timing, etc. The consensus treatment plan helps provide greater consistency in treatment. Perhaps more importantly, it will help researchers understand the best ways treat the disease.read more

Why we formed the Systemic JIA Foundation

Jonathan Boutelle | February 6, 2015 | Leave a Comment

blogheaderimg-02In February of 2013, our healthy one year old son caught a cold which turned into fever and rash and lasted 15 days. After numerous blood tests, and time in the hospital, we received the diagnosis of Systemic JIA. Our lives were changed forever. Basically his immune system was attacking his body. The treatment was massive doses of steroids, and a new “biologic” drug called Anakinra, which required daily injections and was intended to disrupt his body’s inflammation response.read more

  • « Previous Page
  • 1
  • 2
  • 3

Sign Up For Email Updates

Browse by Topic

  • NextGen Drugs
  • Events
  • Clinical Trials
  • Photos & Videos
  • Community Posts

Recent Comments

  • 22 Jan 2019
    Frank Jones said:Sorry guys, I thought this was an email not a public comment. Thank… on - Systemic JIA Foundation is a IRS approved 501(c)(3) charity now
  • 22 Jan 2019
    Frank Jones said:Hello, I am a father of a SJIA kid. We are having a fund raiser at my work and… on - Systemic JIA Foundation is a IRS approved 501(c)(3) charity now
  • 26 Sep 2018
    Jeanne said:I have had problems with my ears for the past 30 years due to inflammation. I have been put… on - Vamorolone: A steroid replacement with fewer side effects
  • 31 Jul 2018
    Catherine said:So, I recommended this(TADEKINK ALFA) I did my research to the family's father, he did what he had to do,… on - IL 18 Binding Protein (tadekinig alfa) gets Breakthrough Therapy and Orphan status from FDA
  • 20 Jun 2018
    Maria Torresan said:I have a rare disease call Idiopathic Subglottic Stenosis. Where my body is attacking its self creating scar tissue that… on - Vamorolone: A steroid replacement with fewer side effects

More Comments

Blog Archives

  • December 2018
  • May 2018
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • January 2017
  • October 2016

More Archives

Populer Blog Posts

  • Save the date for 2019 SJIA Family Conference: June 28th & 29th
  • Systemic JIA Foundation is a IRS approved 501(c)(3) charity now
  • Systemic JIA Family Conference this week & Schedule for first day

More from The Blog

Tags

Actemra Advise for Patients Anakinra Canakinumab Clinical Trials Conferences Family Day IL18 Ilaris Kineret Lung Disease lung infection mas Methotrexate New Drugs Next-Gen Conference Patients Patients Stories Photos pjp Research sjia SJIA Community SJIA Drugs SJIA Foundation SJIA in Media SJIA Meds Steroids Tocilizumab Video Presentations

Contact Us!

Quick Links

  • About Us
  • Research Focus
  • Parents Advisory Board
  • Blog
  • Join Us

For Patients

  • Patient Resources
  • Find Clinical Trials

Donate

  • Donate to SJIA Research

Contact Us

Location 3584 Outlook Avenue, Cincinnati OH, 45208

Email Address info@systemicjia.org

SIGN UP FOR EMAIL UPDATES

© 2019 The Systemic JIA Foundation is a 501(c)(3) non-profit organization. All Rights Reserved.

Disclaimer

This website is provided for educational and informational purposes only. Systemic JIA Foundation is not engaged in rendering medical advice or professional services and this information should not be used for diagnosing or treating a health problem. The site authors and the content providers make no representation or warranties, expressed or implied. Providing links to other websites does not imply that Systemic JIA Foundation endorses the information or services provided on those websites. The organizations operating those websites are solely responsible for the content found on their websites.